One abietane-type and one dinoricetexane-type diterpenoid, salviskin A (1) and salviskin B (2), respectively, together with fourteen known diterpenoids, were isolated from Salvia przewarskii. Structural elucidation of these compounds was performed by spectroscopic methods including 2D NMR. The compounds isolated were evaluated for their cytotoxicity against HeLa and HL-60 cells.
According to Flora of China, 126 species of Salvia are found in China [1] , for which there are still many taxonomical problems, especially in Yunnan and Sichuan Provinces. Thus, during the course of our plant diversity study focusing on secondary metabolites [2], we have been investigating the chemical constituents of Salvia species in these areas of China [3] . S. przewarskii Maxim. is widely distributed in this area and is used to treat cardiovascular diseases [4] . So far, various types of terpenoids have been isolated from this plant. The samples of S. przewarskii used in this study were collected in Sichuan Province, China, in 2009. Herein we report new abietane-type and dinoricetexane-type diterpenoids, together with fourteen known diterpenoids from S. przewarskii.
The roots of S. przewarskii were crushed and extracted with MeOH. The MeOH-soluble materials were partitioned between EtOAc and water. The EtOAc-soluble materials were separated by ODS and silica-gel column chromatography, followed by ODS-HPLC to yield the new compounds 1 and 2, together with known compounds, grandifolia C (3) [5] , ferruginol (4) [6] , 6,7-dehydroferruginol (5) [7] , przewalskin (6) [8] , yunnannin A (7) [9] , militibetin A (8) [10] , deoxofaveline (9) [11] , isograndifoliol (10) [12] , tanshinone IIA (11) [8] , przewaquinone A (12) [8] , cryptotanshinone (13) [13] , ganxintriol B (14) [14] , dehydrotanshinone I (15) [15] , and przewaquinone B (16) [16] (Figure 1 ). Salviskin A (1) was obtained as a colorless, amorphous solid. Its molecular formula was determined as C 20 H 30 O 2 by HRMS [m/z 302.2247,  +0.1 mmu], and its IR spectrum implied the presence of an aromatic moiety (1713, 1670, 1613, and 1574 cm -1 ) and hydroxy group(s) (3362 cm -1 ). The gross structure of 1 was deduced from detailed analysis of the 1 H and 13 C NMR spectra (Table 1) , as well as DEPT and 2D NMR experiments (COSY, HSQC, and HMBC), which suggested the presence of five methylenes, one sp 3 methine, two aromatic methines, three sp 3 quaternary carbons (including one oxygenated carbon), five methyl carbons, three an aromatic ring attached at C-9 and C-8 of ring B was deduced from the HMBC correlations H-7/C-14; H-14/C-9, C-12, and C-7; and H-12/C-9. The HMBC correlations H 3 -16/C-15, C-13, and C-17; H 3 -17/C-15, C-13, and C-16; H-12/C-15; and H-14/C-15 indicated that compound 1 has an abietane skeleton. Finally, the cross peaks of OH ( H 7.93)/C-11, and C-12; and OH ( H 3.73)/ C-13, C-15, C-16 and C-17 demonstrated that one hydroxy group was attached at C-11 and another was located at C-15 of the isopropyl unit. Therefore, the gross structure of salviskin A was elucidated as 1, an abietane-type diterpenoid. The NOESY correlations H 3 -18/H-3 and H-5; and H 3 -19/H 3 -20 and H-3indicated that H 3 -20 was -oriented and H-5 was -oriented.
Salviskin B (2) was also obtained as a colorless, amorphous solid. Its molecular formula was determined as C 18 H 22 O by HRMS [m/z 254.1672,  +0.1 mmu], and its IR spectrum suggested the presence of a hydroxy group (3331 cm -1 ) and an aromatic moiety (1716, 1612, and 1577 cm -1 ). The UV spectrum showed  max (MeOH) at 288 (log  2.81) nm. The 13 C NMR spectrum showed four methylenes, four sp 2 methines, one sp 3 quaternary carbon, six sp 2 quaternary carbons (including one oxygenated carbon), two quaternary methyls, and one methyl attached to an aromatic ring. With two double bonds and an aromatic ring accounting for a degree of unsaturation of six (out of eight), it was suggested that 2 contains two rings, besides an aromatic ring. The 1 H-1 H COSY spectrum demonstrated connectivities of C-1 to C-3, and C-6 to C-7 ( Figure 2 ). The following HMBC correlations were observed: H-1/C-3, and C-5; H-2/C-4, and C-10; H-3/C-1, C-4, C-18, and C-19; H 3 -18/C-4, and C-5; and H 3 -19/C-18, and C-4. These correlations suggested that compound 2 has a decalin skeleton with a dimethyl unit at C-4 (ring A). The following correlations were also observed: H-11/C-8, C-12 ( C 154.1), and C-13; H-14/C-9, and C-12; H 3 -15 ( H 2.23)/C-12, C-13, and C-14. These cross peaks suggested an aromatic ring containing a hydroxy group at C-12 and a methyl group at C-13 (ring C). The remaining ring (ring B) between rings A and C was deduced to be a 7-membered ring from unsaturation. The following HMBC correlations were observed: H-20/C-10, C-5, C-8 C-9, C-1, and C-11; H-6/C-10, C-7, and C-8; H-7/C-5, and C-14. Thus, the remaining ring B was a 7-membered ring with  5,  and  6, 7 double bonds. Therefore, the gross structure of salviskin B was elucidated as 2, a dinoricetexane-type diterpenoid. The NOESY correlations H 3 -18 and H 3 -19/H-6; H 3 -18, H 3 -19/H-3; and H-1/H-20 further supported the proposed structure of 2.
The isolated compounds were evaluated for their cytotoxicity against human cervical cancer, HeLa, and human promyelocytic leukemia, HL-60, cell lines (Table 2) [17] . Tanshinone IIA (11) and przewaquinone A (12) exhibited significant cytotoxicity against HeLa and HL-60 cells (IC 50 : 11 = 2.8, 2.3 M, respectively; 12 = 3.4, 2.2 M, respectively). Salviskin B (2) and compounds 3, 10, and 13-16 exhibited weak activity against HeLa cells, with IC 50 values in the range of 13.9~35.4 M. Furthermore, isograndifoliol (10) exhibited potent activity against HL-60 cells with an IC 50 value of 0.33M. Cryptotanshinone (13) , dehydrotanshinone I (15) and przewaquinone B (16) exhibited significant activity against HL-60 cells (IC 50 : 13 = 9.4M; 15 = 3.6 M; 16 =3.0 M). Salviskin B (2), compounds 3-6, and 14 exhibited weak activity against HL-60 cells, with IC 50 values in the range of 11.0~41.4 M. 
Experimental
General: Optical rotation was measured on a JASCO DIP-370. 1 H and 13 C NMR spectra were obtained on Bruker AVANCE 500 and JEOL ECA 500 spectrometers using tetramethylsilane as the internal standard. HR-EI-MS spectra were obtained on a JEOL HX-100. UV and IR spectra were measured on JASCO V-560 UV/VIS and JASCO FT/IR-5300 spectrometers, respectively. For column chromatography, ODS (ODS-AM, YMC) and silica-gel (Wakogel C-300, Wako Pure Chemical Ind.) were used. HPLC was performed using YMC-Pack ODS-AM (YMC; 10x250 mm), Develosil ODS HG-5 (Nomura Chemical; 10x250 mm).
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Natural Product Communications Vol. 11 (2) 2016 161 was partitioned between n-hexane and 90% MeOH aq., and then MeOH-soluble materials were partitioned between EtOAc and water. EtOAc-soluble materials (9.5 g) were fractionated using an ODS column (MeCN/H 2 O, 20:80→0:100, MeOH, CHCl 3 ), producing 6 fractions. Fraction C (MeCN/H 2 O, 20:80) was separated using a silica-gel column (n-hexane/CHCl 3 and/or n-hexane/EtOAc), and then ODS-HPLC to give salviskin A (1, 0.7 mg), salviskin B (2, 2.6 mg), grandifolia C (3, 15.4 mg), przewalskin (6, 31.2 mg), yunnaninn A (7, 0.7 mg), militibeline A (8, 1.3 mg), deoxofavelin (9, 2.3 mg), isograndifoliol (10, 8.0 mg), przewaquinone A (12, 10.4 mg), cryptotanshinone (13, 9.8 mg) , ganxintriol B (14) , dehydrotanshinone I (15, 13.9 mg), and przewaquinone B (16, 10.7 mg). Furthermore, fraction D (MeCN) was separated using a silica-gel column (n-hexane/CHCl 3 and/or n-hexane/EtOAc) and then ODS-HPLC to give ferruginol (4, 12.4 mg), 6,7-dehydroferruginol (5, 2.8 mg), tanshinone IIA (11, 3.2 mg), and cryptotanshinone (13, 1.4 mg). 
